Feline Tritrichomonosis (Tritrichomonas foetus Infection)

Feline tritrichomonosis is an enteric protozoan infection caused by Tritrichomonas foetus, a flagellated anaerobic parasite that colonizes the large intestine of domestic cats, resulting in chronic, often intractable large-bowel diarrhea [1]. While the same organism is responsible for bovine venereal tritrichomonosis and acts as an essentially apathogenic commensal in the nasal cavity of pigs, the feline form is transmitted by the fecal-oral route rather than sexually, representing a distinct epidemiological pattern [1]. The disease has been recognized worldwide and is considered an emerging enteric pathogen of particular concern in multi-cat households, catteries, and shelters, where crowding facilitates transmission [6]. Whole-genome sequencing has revealed massive genetic differences between feline, bovine, and porcine isolates of T. foetus, raising important questions about host-specific adaptation and interspecies transmission risks [1].

Tritrichomonas foetus is a pear-shaped, flagellated protozoan measuring approximately 10–25 µm in length, belonging to the phylum Parabasalia. The organism possesses three anterior flagella and one recurrent flagellum forming an undulating membrane, propelling it with a characteristic rolling motility [4]. Whole-genome analysis has confirmed that feline isolates are genetically highly divergent from their bovine and porcine counterparts, suggesting significant host-specific evolutionary adaptation [1].

In cats, T. foetus colonizes predominantly the ileum, cecum, and colon, where it adheres to and disrupts the intestinal epithelium. The parasite induces a lymphoplasmacytic and neutrophilic colitis, damaging the mucosal barrier, impairing fluid and electrolyte reabsorption, and stimulating excess mucus secretion—all of which contribute to the characteristic large-bowel diarrhea [4]. The organism does not form cysts, existing only as trophozoites, which are shed directly in feces and remain viable in moist environments long enough to facilitate fecal-oral transmission [1].

Transmission occurs most efficiently in settings of high cat density, such as multi-cat households, shelters, and catteries, where fecal contamination of shared food bowls, water sources, or litter boxes is common [6]. Prevalence studies in Poland identified significant associations between infection and housing conditions, with pedigree and shelter cats showing higher infection rates than random-bred individuals [6]. Young cats, particularly those under two years of age, appear most susceptible, possibly due to immature intestinal immunity, though adult cats are also affected [3][4]. Molecular epidemiological evidence indicates that interspecies transmission between cattle, pigs, and cats is a realistic scenario given shared environments in rural settings [1].

Two intestinal trichomonads have been described in cats: the pathogenic T. foetus and the presumably non-pathogenic Pentatrichomonas hominis; the two are morphologically indistinguishable by light microscopy alone, making molecular confirmation essential [2].

Clinical Suspicion

Diagnosis should be suspected in any cat—especially young, pedigree, or shelter-housed cats—presenting with chronic, mucoid, large-bowel diarrhea that has failed to respond to standard dietary management, antibiotics, or antiparasitic therapy [3][4].

Direct Fecal Smear Microscopy

Fresh feces (ideally examined within 6 hours of collection) can be evaluated by wet mount preparation. T. foetus trophozoites display a distinctive forward-rolling motility. However, sensitivity is low because trophozoite numbers may be sparse, and morphological distinction from Pentatrichomonas hominis is not possible by microscopy alone [2][4].

Fecal Culture — InPouch™ TF-Feline

The InPouch™ TF-Feline medium (Bio-Med Diagnostics) has historically been considered the gold standard for culture-based diagnosis. Feces are inoculated into the pouch and incubated at 37°C; motile trichomonads are examined microscopically over several days. However, a critical limitation is that this medium is not specific for T. foetus—P. hominis and other trichomonads can also grow and be misidentified, leading to false-positive results [2]. Culture findings must therefore be confirmed by molecular methods.

PCR (Polymerase Chain Reaction)

PCR targeting the T. foetus ITS (Internal Transcribed Spacer) region or other gene loci (e.g., β-tubulin, elf1α) is the most sensitive and specific diagnostic method currently available [5]. Both conventional PCR and real-time (quantitative) PCR have been validated for feline fecal samples. Real-time PCR offers superior sensitivity compared to conventional PCR and is preferred for clinical samples with low parasite loads [5].

LAMP (Loop-Mediated Isothermal Amplification)

LAMP assays targeting the β-tubulin and elf1α genes of T. foetus have been developed and evaluated as rapid, field-applicable alternatives to PCR. Comparative studies demonstrated that novel LAMP and novel real-time PCR assays showed comparable sensitivity, though performance varied depending on the gene target and assay design [5]. LAMP may offer advantages in resource-limited settings due to simpler equipment requirements.

Clinicopathological Laboratory Findings

Routine bloodwork is often unremarkable in uncomplicated feline tritrichomonosis, reflecting its localized colonic nature. However, in cats with prolonged or severe disease the following may be noted:

• ·Hypoalbuminemia (low ALB): Protein-losing enteropathy from chronic mucosal damage
• ·Low body weight / body condition score: Nutritional depletion
• ·Mild leukocytosis (elevated WBC): Possible in cats with secondary bacterial translocation or concurrent illness
• ·Mildly elevated globulins (GLOB): Chronic antigenic stimulation
• ·Hematocrit (HCT): May be low in cats with significant hematochezia
• ·Liver enzymes (ALT), renal markers (BUN, CREA), and platelet count (PLT) are typically within normal limits unless concurrent disease is present

Differential Diagnosis

Key differentials include inflammatory bowel disease (IBD), Giardia infection, Cryptosporidium infection, Clostridium perfringens-associated diarrhea, dietary intolerance, and feline panleukopenia—all of which may produce overlapping large-bowel signs [4].

Ronidazole — Drug of Choice

Ronidazole is the only antimicrobial with demonstrated clinical efficacy against T. foetus in cats and is considered the treatment of choice. The standard protocol is 30 mg/kg orally once daily for 14 days [3]. In a clinical study involving 17 pedigree cats in poor health in an Austrian shelter, treatment with this protocol resulted in 11 of 14 initially PCR-positive cats remaining negative for T. foetus during the 6–8 week follow-up period, representing an approximately 79% clearance rate [3].

Neurological side effects are the primary safety concern with ronidazole; these include ataxia, tremors, and seizures, which are dose-dependent and reversible upon discontinuation [3]. Close monitoring throughout the treatment period is essential. In the study by Hinney et al. (2019), treatment was generally tolerated despite pre-existing health conditions in the cats, but vigilance is required [3].

Important note: Ronidazole is not licensed for use in cats in many countries and must be compounded; its use is considered extra-label. Clinicians must obtain appropriate informed consent and comply with local regulatory requirements.

Metronidazole — Ineffective

Metronidazole, while commonly used for other protozoan and anaerobic bacterial infections in cats, has no demonstrated efficacy against T. foetus and should not be used as a primary treatment. Its use may temporarily suppress clinical signs without clearing the infection.

Supportive Care

• ·Dietary modification: Highly digestible, low-fiber or hydrolyzed protein diets may help reduce the severity of diarrhea during the treatment period
• ·Probiotics: May support restoration of normal intestinal flora; evidence in this specific condition is limited
• ·Fluid and electrolyte support: In severely dehydrated cats, subcutaneous or intravenous fluid therapy is indicated
• ·Nutritional support: Cats with significant weight loss or hypoalbuminemia may benefit from nutritional supplementation

Environmental Decontamination

Because no cyst stage exists and trophozoites are environmentally labile under dry conditions, rigorous cleaning and disinfection of litter boxes, food/water bowls, and bedding is a key adjunct to pharmacological treatment [1].

The prognosis for feline tritrichomonosis is generally favorable with respect to survival; mortality directly attributable to T. foetus infection alone is low, and the disease is not typically life-threatening in otherwise healthy cats [3][4].

However, the prognosis for complete parasitological cure is guarded without specific treatment. In cats that remain untreated, symptoms may persist for months to years, though some individuals may experience spontaneous improvement of clinical signs over time as intestinal immunity matures, even if the organism persists [3].

With ronidazole treatment at 30 mg/kg PO q24h for 14 days, approximately 79% of treated cats (11/14) tested negative for T. foetus by PCR at 6–8 weeks post-treatment in a clinical shelter study [3]. The remaining cats that tested positive after treatment may require re-evaluation, extended treatment, or management of reinfection from environmental sources or untreated in-contact cats.

Cats with concurrent illnesses—such as viral immunosuppression (FIV, FeLV), IBD, or severe malnutrition—may have a more complicated course and poorer response to treatment [3]. In the study by Hinney et al. (2019), pre-existing poor health conditions did not preclude successful treatment outcomes in the majority of cats, but close monitoring remains essential [3].

Long-term reinfection is a significant concern in multi-cat households and catteries where all in-contact cats are not simultaneously treated and environmental control is inadequate. No peer-reviewed data on long-term (>12-month) recurrence rates were identified in the references cited above.

Explicit all-cause mortality statistics specific to feline tritrichomonosis were not directly reported in the referenced literature, reflecting the generally non-fatal nature of this disease in typical clinical presentations.

Environmental and Husbandry Measures

• ·Reduce crowding: Limiting cat density in catteries, shelters, and multi-cat households is the single most effective preventive measure, as overcrowding directly facilitates fecal-oral transmission [6]
• ·Litter box hygiene: Frequent cleaning and disinfection of litter boxes (daily scooping, regular complete disinfection with hot water and detergent) are essential
• ·Separate food and water sources: Communal bowls facilitate fecal contamination; individual feeding stations reduce risk
• ·Quarantine new arrivals: New cats entering a household or cattery should be tested for T. foetus by PCR and quarantined until confirmed negative before integration [3]

Testing and Screening Programs

• ·Routine PCR screening of breeding cats and newly acquired animals is strongly recommended in catteries with a history of chronic diarrhea [3][5]
• ·All in-contact cats in an affected household should be tested simultaneously to identify subclinically infected carriers who maintain environmental contamination

Treatment of All Positive Animals

In a multi-cat setting, treating index cases alone is insufficient; all PCR-positive cats—including those without overt clinical signs—should receive ronidazole therapy to eliminate the reservoir [3].

Biosecurity in Shelters

Shelter protocols should include routine fecal screening of incoming cats, isolation of animals with diarrhea, and staff education about fecal-oral transmission routes [3][6].

No Vaccine Available

There is currently no commercially available vaccine against T. foetus for cats. Prevention relies entirely on management, hygiene, and early detection and treatment of infected individuals.